Anti-influenza Activity of a Bacillus subtilis Probiotic Strain

scientific article published on 17 April 2017

Anti-influenza Activity of a Bacillus subtilis Probiotic Strain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.00539-17
P932PMC publication ID5487639
P698PubMed publication ID28416546

P2093author name stringIryna Sorokulova
Darya Starosila
Ludmila Varbanetz
Naila Ivanskaya
Svetlana Rybalko
P2860cites workCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Proteomics characterization of abundant Golgi membrane proteinsQ28141807
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritisQ28258829
In-gel digestion for mass spectrometric characterization of proteins and proteomesQ29547583
Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cellsQ30357092
Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis.Q30385184
An update on the use and investigation of probiotics in health and diseaseQ30407565
Bioactive microbial metabolitesQ31157729
Viral exploitation and subversion of the immune system through chemokine mimicryQ33933260
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.Q33983372
Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflowQ34002643
Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrinQ34424372
Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults.Q35771988
Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell ImmunityQ35901914
Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1.Q36799919
Microbiota restoration: natural and supplemented recovery of human microbial communitiesQ37813012
Probiotics and health: an evidence-based reviewQ37846909
Probiotics in respiratory virus infections.Q38196730
Antimicrobial peptides of the genus Bacillus: a new era for antibiotics.Q38335550
Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines CommitteeQ38695796
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesQ38803189
Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an exampleQ40136000
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cellsQ40231712
Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14.Q40693087
Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patientsQ41626984
Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury miceQ41653544
Oral intake of Lactobacillus rhamnosus M21 enhances the survival rate of mice lethally infected with influenza virusQ41706073
Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccineQ44348398
The efficacy of the new bacterial preparation biosporin in treating acute intestinal infectionsQ50140899
Structural and functional studies of Peptide-carbohydrate mimicry.Q51054716
Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis.Q52527435
Probiotics against Campylobacter PathogensQ77553286
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectBacillus subtilisQ131238
probioticsQ1816730
P577publication date2017-06-27
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleAnti-influenza Activity of a Bacillus subtilis Probiotic Strain
P478volume61

Reverse relations

cites work (P2860)
Q47159058Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4'-diaponeurosporene-producing Bacillus subtilis
Q64900236Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies.
Q98578835The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?

Search more.